Detalhe da pesquisa
1.
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study.
Future Oncol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629593
2.
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib.
Future Oncol
; 19(3): 217-228, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749292
3.
Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancer.
Cancer Treat Res Commun
; 33: 100637, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162323